BeStock  
Stocks › AI medical concept stocks › TDOC

Teladoc Health TDOC

US equityMarket cap rank #3234AI medical concept stocks
$5.56 −$0.21 (-3.64%)
Pre-market · Oct 8, 8:20 am ET · After hours $5.56 0.00%
Open$5.76
Prev close$5.77
Day range$5.53 – $5.76
Volume3.62M
Market cap$1.01B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.8%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+27.0%
Worst reaction-28.3%

Stock move on the day after each report

-3.9%2023/Q3-23.7%2023/Q4-2.4%2024/Q1-8.9%2024/Q2+1.6%2024/Q3-13.6%2024/Q4-2.8%2025/Q1-1.7%2025/Q2+6.2%2025/Q3+15.1%2025/Q4+1.8%2026/Q1-28.3%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q229 Jul 2026After Market±9.5%-28.32%Bigger than priced
2026/Q129 Apr 2026After Market±8.0%+1.85%Within range
2025/Q425 Feb 2026After Market±9.2%+15.05%Bigger than priced
2025/Q329 Oct 2025After Market±7.9%+6.20%Within range
2025/Q229 Jul 2025After Market±11.8%-1.73%Within range
2025/Q130 Apr 2025After Market±13.7%-2.78%Within range
2024/Q426 Feb 2025After Market±14.1%-13.56%Within range
2024/Q330 Oct 2024After Market±13.2%+1.58%Within range
2024/Q231 Jul 2024After Market±15.8%-8.91%Within range
2024/Q125 Apr 2024After Market±14.1%-2.40%Within range
2023/Q420 Feb 2024After Market±17.0%-23.67%Bigger than priced
2023/Q324 Oct 2023After Market±14.0%-3.92%Within range
2023/Q225 Jul 2023After Market±13.3%+26.95%Bigger than priced
2023/Q126 Apr 2023After Market±13.0%+6.36%Within range
2022/Q422 Feb 2023After Market±15.8%-6.80%Within range
2022/Q326 Oct 2022After Market±18.2%+6.47%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • Integrated Care$394.31M 65.0%
  • BetterHelp$212.62M 35.0%

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$606.93M-4.0% YoY
Operating profit-$34.50M+25.1% YoY
Net profit-$38.91M-19.1% YoY
Diluted EPS-$0.21-10.5% YoY
Free cash flow$23.07M-27.1% YoY
Operating cash flow$64.66M

Revenue, last 8 quarters

$640.5MSep '24$640.5MDec '24$629.4MMar '25$631.9MJun '25$626.4MSep '25$642.3MDec '25$613.8MMar '26$606.9MJun '26

Net profit, last 8 quarters

$-33.3MSep '24$-48.4MDec '24$-93.0MMar '25$-32.7MJun '25$-49.5MSep '25$-25.1MDec '25$-63.8MMar '26$-38.9MJun '26

Profitability & balance sheet

Gross margin69.0%
Operating margin-5.9%
Net margin-7.1%
Return on equity-13.0%
Return on assets-6.3%
Return on invested capital-7.7%
Current ratio0.83
Liabilities / assets52.5%
Cash & investments$774.35M
Total debt$1.03B
Net cash (debt)-$251.89M
Free cash flow / sales4.7%

Discussion

No comments yet — be the first to weigh in on TDOC.

Leave a comment

Scroll to Top